Hugh A Sampson, MD: Clinical Trials

3 completed. 3 Phase 2, 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	3	Completed 3
Phase 1	1	Completed 1

Follow Hugh A Sampson, MD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Oral Immunotherapy for Wheat Allergy Wheat OIT - Wheat Allergy	Phase 1 / Phase 2	Completed	Hugh A Sampson, MD	46	2013-10-01	2020-08-14
Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy Egg Oral Immunotherapy, Baked Egg - Food Allergy	Phase 2	Completed	Hugh A Sampson, MD	92	2013-07-01	2019-07-26
OIT and Xolair® (Omalizumab) in Cow's Milk Allergy Placebo for omalizumab, Omalizumab, Milk powder - Milk Allergy	Phase 2	Completed	Hugh A Sampson, MD	77	2010-08-01	2020-08-14

Conditions studied

Food Hypersensitivity (3)  ·  Egg Hypersensitivity (1)  ·  Milk Hypersensitivity (1)  ·  Wheat Hypersensitivity (1)

Interventions

Omalizumab (1)  ·  Refit milk powder (1)

Countries

United States (3)

Top investigators

Hugh A. Sampson, M.D. (1)  ·  Robert Wood, MD (1)

Results publications

PMID 25609353, PMID 26581915

NIH funding

U19AI044236 (1), U19AI066738 (1)